Learning to predict cancer-associated skeletal muscle wasting from 1H-NMR profiles of urinary metabolites

Metabolomics

Volumn 7, Issue 1, 2011, Pages 25-34

  Eisner, Roman ^a   Stretch, Cynthia ^a   Eastman, Thomas ^a   Xia, Jianguo ^a   Hau, David ^a   Damaraju, Sambasivarao ^a   Greiner, Russell ^a   Wishart, David S ^a   Baracos, Vickie E ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cancer; Machine learning; Muscle wasting; NMR; Urine

Indexed keywords

3 HYDROXYISOVALERIC ACID; ALANINE; CREATINE; CREATININE; GLYCINE; ISOLEUCINE; ISOVALERIC ACID; LEUCINE; SERINE; THREONINE; TYROSINE; UNCLASSIFIED DRUG; VALINE;

ACCURACY; ADULT; ARTICLE; BAYES THEOREM; BIVARIATE ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DECISION TREE; DISCRIMINANT ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; IMAGE ANALYSIS; LUMBAR SPINE; MACHINE LEARNING; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MUSCLE ATROPHY; NUCLEAR OVERHAUSER EFFECT; PARTIAL LEAST SQUARES REGRESSION; PATIENT SAFETY; PREDICTION; PROTON NUCLEAR MAGNETIC RESONANCE; RISK ASSESSMENT; SKELETAL MUSCLE; SUPPORT VECTOR MACHINE; URINALYSIS; VALIDATION STUDY;

EID: 79951727039     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-010-0232-9     Document Type: Article

References (40)

1. Akcay, M. N., Akcay, G., Solak, S., Balik, A. A., & Aylu, B. (2001). The effect of growth hormone on 24-h urinary creatinine levels in burned patients. Burns, 27, 42-45.
2. Antoun, S., Baracos, V. E., Birdsell, L., Escudier, B., & Sawyer, M. B. (2010). Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma. Annals of Oncology, 21, 1594-1598.
3. Asp, M. L., Tian, M., Wendel, A. A., & Belury, M. A. (2009). Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice. International Journal of Cancer, 126, 756-763.
4. Bertini, I., Calabro, A., De Carli, V., Luchinat, C., Nepi, S., Porfirio, B., et al. (2009). The metabonomic signature of celiac disease. J Proteome Research, 8, 170-177.
5. Bidlingmeyer, B. A., Cohen, S. A., & Tarvin, T. L. (1984). Rapid analysis of amino acids using pre-column derivatization. J Chromatography, 336, 93-104.
6. Bollard, M. E., Stanley, E. G., Lindon, J. C., Nicholson, J. K., & Holmes, E. (2005). NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition. NMR in Biomedicine, 18, 143-162.
7. Cover, T. M., & Thomas, J. A. (2006). Elements of information theory. Hoboken, NJ: Wiley-Interscience.
8. Craig, A., Cloarec, O., Holmes, E., Nicholson, J. K., & Lindon, J. C. (2006). Scaling and normalization effects in NMR spectroscopic metabonomic data sets. Analytical Chemistry, 78, 2262-2267.
9. 1H NMR metabonomics. Analytical Chemistry, 78, 4281-4290.
10. Eastman, T. (2010). A disease classifier for metabolic profiles based on metabolic pathway knowledge. MSc Thesis, University of Alberta.
11. Evans, W. J., Morley, J. E., Argiles, J., Bales, C., Baracos, V., Guttridge, D., et al. (2008). Cachexia: A new definition. Clinical Nutrition, 27, 793-799.
12. Friedman, N., Geiger, D., & Goldszmidt, M. (1997). Bayesian network classifiers. Machine Learning, 29, 131-163.
13. Hastie, T., Tibshirani, R., & Friedman, J. H. (2001). The elements of statistical learning: Data mining, inference, and prediction: With 200 full-color illustrations. New York: Springer.
14. Heymsfield, S. B., Wang, Z., Baumgartner, R. N., & Ross, R. (1997). Human body composition: Advances in models and methods. Annual Review of Nutrition, 17, 527-558.
15. 1H nuclear magnetic resonance spectra of human urine from normal and pathological states. Analytical Biochemistry, 220, 284-296.
16. Kanehisa, M., Araki, M., Goto, S., Hattori, M., Hirakawa, M., Itoh, M., et al. (2008). KEGG for linking genomes to life and the environment. Nucleic Acids Research, 36, D480-D484.
17. Lieffers, J. R., Mourtzakis, M., Hall, K. D., Mccargar, L. J., Prado, C. M., & Baracos, V. E. (2009). A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: Contributions of organ and tumor mass to whole-body energy demands. American Journal of Clinical Nutrition, 89, 1173-1179.
18. Mahadevan, S., Shah, S. L., Marrie, T. J., & Slupsky, C. M. (2008). Analysis of metabolomic data using support vector machines. Analytical Chemistry, 80, 7562-7570.
19. Mitsiopoulos, N., Baumgartner, R. N., Heymsfield, S. B., Lyons, W., Gallagher, D., & Ross, R. (1998). Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. Journal of Applied Physiology, 85, 115-122.
20. Mourtzakis, M., Prado, C. M., Lieffers, J. R., Reiman, T., Mccargar, L. J., & Baracos, V. E. (2008). A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Applied Physiology, Nutrition and Metabolism, 33, 997-1006.
21. Pesarin, F. (2001). Multivariate permutation tests: With applications in biostatistics. Chichester, New York: J. Wiley.
22. Prado, C. M., Baracos, V. E., Mccargar, L. J., Mourtzakis, M., Mulder, K. E., Reiman, T., et al. (2007). Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clinical Cancer Research, 13, 3264-3268.
23. Prado, C. M., Lieffers, J. R., Mccargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., et al. (2008). Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study. Lancet Oncology, 9, 629-635.
24. Prado, C. M., Baracos, V. E., Mccargar, L. J., Reiman, T., Mourtzakis, M., Tonkin, K., et al. (2009). Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clinical Cancer Research, 15, 2920-2926.
25. Quinlan, J. R. (1993). C4. 5: Programs for machine learning. San Mateo, CA: Morgan Kaufmann Publishers.
26. Ross, R. (2003). Advances in the application of imaging methods in applied and clinical physiology. Acta Diabetologica, 40(Suppl 1), S45-S50.
27. Saude, E. J., & Sykes, B. D. (2007). Urine stability for metabolomic studies: Effects of preparation and storage. Metabolomics, 3, 19-27.
28. Shen, W., Punyanitya, M., Wang, Z., Gallagher, D., St-Onge, M. P., Albu, J., et al. (2004a). Total body skeletal muscle and adipose tissue volumes: Estimation from a single abdominal cross-sectional image. Journal of Applied Physiology, 97, 2333-2338.
29. Shen, W., Punyanitya, M., Wang, Z., Gallagher, D., St-Onge, M. P., Albu, J., et al. (2004b). Visceral adipose tissue: Relations between single-slice areas and total volume. American Journal of Clinical Nutrition, 80, 271-278.
30. Slupsky, C. M., Rankin, K. N., Wagner, J., Fu, H., Chang, D., Weljie, A. M., et al. (2007). Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Analytical Chemistry, 79, 6995-7004.
31. Tan, B. H., Birdsell, L. A., Martin, L., Baracos, V. E., & Fearon, K. C. (2009). Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clinical Cancer Research, 15(22), 6973-6979.
32. Wagner, A., & Fell, D. A. (2001). The small world inside large metabolic networks. Proceedings of the Royal Society of Biological Science, 268, 1803-1810.
33. Walsh, M. C., Brennan, L., Malthouse, J. P., Roche, H. M., & Gibney, M. J. (2006). Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans. American Journal of Clinical Nutrition, 84(3), 531-539.
34. Wang, X., Hu, Z., Hu, J., Du, J., & Mitch, W. E. (2006). Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteosome pathway by defects in muscle cell signaling. Endocrinology, 147, 4160-4168.
35. 1H NMR metabolomics data. Analytical Chemistry, 78, 4430-4442.
36. Westerhuis, J. A., Hoefsloot, H. C. J., Smit, S., Vis, D. J., Smilde, A. K., van Velzen, E. J. J., et al. (2008). Assessment of PLSDA cross validation. Metabolomics, 4, 81-89.
37. Wishart, D. S. (2007). Current progress in computational metabolomics. Briefings in Bioinformatics, 8, 275-284.
38. Wishart, D. S. (2008). Quantitative metabolomics using NMR. Trends in Analytical Chemistry, 27, 228-237.
39. Wishart, D. S., Tzur, D., Knox, C., Eisner, R., Guo, A. C., Young, N., et al. (2007). HMDB: The Human Metabolome Database. Nucleic Acids Research, 35(Database issue), D521-D526.
40. Witten, I. H., & Frank, E. (2005). Data mining: Practical machine learning tools and techniques. Boston, MA: Morgan Kaufman.